Bulletin of the Korean Chemical Society

  • 제30권12호
  • /
  • Pages.2879-2880
  • /
  • 2009
  • /
  • 0253-2964(pISSN)
  • /
  • 1229-5949(eISSN)
대한화학회 (Korean Chemical Society)
권호 표지
DOI QR코드

DOI QR Code

Antihyperglycemic Effects of Methylenedisalicylic Acid

  • Bhattarai, Bharat Raj (Department of Chemistry, College of Natural Science, Inha University) ;
  • Lee, Keun-Hyeung (Department of Chemistry, College of Natural Science, Inha University) ;
  • Cho, Hyeong-Jin (Department of Chemistry, College of Natural Science, Inha University)
  • 발행 : 2009.12.20
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Ogden, C. L.; Carroll, M. D.; Curtin, L. R.; McDowell, M. A.; Tabak, C. J.; Flegal, K. M. JAMA 2006, 295, 1549 https://doi.org/10.1001/jama.295.13.1549
  2. Bassett, M. T. Am. J. Public Health 2005, 95, 1496 https://doi.org/10.2105/AJPH.95.9.1496
  3. Goldstein, B. J. Curr. Drug Targets Immune Endocr. Metabol Disorders 2001, 1, 265 https://doi.org/10.2174/1568008013341163
  4. Shrestha, S.; Bhattarai, B. R.; Chang, K. J.; Lee, K.-H.; Cho, H. Bioorg. Med. Chem. Lett. 2007, 17, 2760 https://doi.org/10.1016/j.bmcl.2007.02.069
  5. Shrestha, S.; Bhattarai, B. R.; Lee, K.-H.; Cho, H. Bioorg. Med. Chem. 2007, 15, 6535 https://doi.org/10.1016/j.bmc.2007.07.010
  6. Bhattarai, B. R.; Ko, J.-H.; Shrestha, S.; Kafle, B.; Cho, H.; Kang, J.-H.; Cho, H. manuscript submitted
  7. Yuan, M.; Konstantopoulos, N.; Lee, J.; Hansen, L.; Li, Z.-W.; Karin, M.; Shoelson, S. E. Science 2001, 293, 1673 https://doi.org/10.1126/science.1061620
  8. Sarmah, A. K.; Meyer, M. T.; Boxall, A. B. A. Chemosphere 2006, 65, 725 https://doi.org/10.1016/j.chemosphere.2006.03.026
  9. Brumm, M. C.; Baysinger, A. K.; Wills, R. W.; Thaler, R. C. J. Anim. Sci. 2002, 80, 309
  10. Radomski, J. L.; Hagan, E. C.; Nelson, A. A.; Welch, H. Antibiot. Chemother. 1954, 4, 304
  11. Davison, C.; Williams, R. T. J. Pharm. Pharmac. 1968, 20, 12 https://doi.org/10.1111/j.2042-7158.1968.tb09612.x
  12. Mouse experiment: Twenty one mice (C57BL/6J Jms Slc, 4-wk old, male, 17 ~ 19 g, Japan SLC, Inc., Haruno Breeding branch, Japan) were individually housed and maintained in a 12 h light/ dark cycle at$22{\pm}2{^{\circ}C}$ Food and water were available ad libitum. A high fat diet (HFD, D12451, New Brunswick, NJ, USA) and low fat diet (LFD, D10012G, New Brunswick) containing 45% and 16% of the calories from fat, respectively, were either in pellet or powder form. All mice were acclimatized for 1 wk (LFD), with 14 mice fed a HFD for the first 8 wk of the study for the development of obesity and diabetes; the remaining 7 were fed a LFD. The mice assigned to the LFD group were maintained on this diet throughout the study as a lean control group. At week 8, all the HFD-fed mice were divided into two groups. Each group was then given a HFD or HFD plus MDSA for 4 wk. The concentration of MDSA in the diets was 5.0 g/kg of diet (0.5% w/w). The LFD was provided in pellet form throughout the experiment. Conversely, the obese/diabetic control and MDSA-treated mice groups were fed with a HFD powdered food mixed with 10% H2O to make a dough. For the treatment with MDSA, 2.5 g of MDSA was dissolved in H2O (50 mL containing 2.0 equivalents of NaOH solution), mixed in powdered food (500 g), and kneaded to form a dough. Body weight and food intake were recorded every 3 d throughout the study. For the glucose tolerance test, mice were fasted for 6 h and glucose (1.0 g/kg of body weight) injected intraperitoneally. Blood glucose levels were measured from tail bleeds with a glucometer (Accu check active, Roche diagnostics, Ireland) at 0 (prior to glucose administration), 20, 40, 60, 90, and 120 min after glucose injection. After a 5 d recovery period on their own diet (the test group on HFD plus MDSA), mice were fasted overnight and blood collected by cardiac puncture under secobarbital anesthesia. Liver, lung, kidney, and white adipose tissue were excised and weighed. Plasma was analyzed for glucose, triglyceride, total cholesterol and free fatty acids using diagnostic kits (Glucose C2, TG E, T-Cho E and NEFA C from Wako Pure Chemical Industries, Ltd. Osaka, Japan)
  13. Surwit, R. S.; Kuhn, C. M.; Cochrane, C.; McCubbin, J. A.; Feinglos, M. N. Diabetes 1988, 37, 1163 https://doi.org/10.2337/diabetes.37.9.1163
  14. Shrestha, S.; Lee, K.-H.; Cho, H. Bull. Korean Chem. Soc. 2004, 25, 1303 https://doi.org/10.5012/bkcs.2004.25.9.1303

피인용 문헌

  1. Isoxazolone Derivatives as Potent Inhibitors of PTP1B vol.33, pp.1, 2012, https://doi.org/10.5012/bkcs.2012.33.1.275
  2. Antiobesity Effect of SA37 in High-Fat Diet-induced Obese C57BL/6J Mice vol.37, pp.5, 2016, https://doi.org/10.1002/bkcs.10730
  3. ChemInform Abstract: Antihyperglycemic Effects of Methylenedisalicylic Acid. vol.41, pp.14, 2010, https://doi.org/10.1002/chin.201014087